Safety and Efficacy Study of Urokinase for the Treatment of Diabetic Foot Syndrome and Critical Limb Ischemia

NCT01638585 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

34

Enrollment

OTHER

Sponsor class

Stopped recruition number was not reached

Conditions

Diabetic Foot
Critical Limb Ischemia

Interventions

DRUG: urokinase

Sponsor

GWT-TUD GmbH